14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for CVAC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.88 4.09 %
R2 2.82 1.82 %
R1 2.78 0.410 %
Current price: 2.77
Support S1 2.66 -4.14 %
S2 2.62 -5.55 %
S3 2.55 -7.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.43 23.83 %
R2 3.42 23.47 %
R1 2.96 6.86 %
Current price 2.77
Support S1 2.65 -4.33%
S2 2.44 -11.91%
S3 2.31 -16.61%

CVAC Predictions History

1 year ago
JS predicted that CVAC for 2022-07-11 is going $14.28 (9.09%)

1 year ago
shakeelcre.327055 predicted that CVAC for 2022-07-11 is going

Rank:

3 years ago
JS predicted that CVAC for 2020-12-08 is going $116.86 (-10.14%)

3 years ago
Dinesh Reddy Devarapally predicted that CVAC for 2020-12-08 is going $106.15 (-7.15%)

Rank:

3 years ago
JS predicted that CVAC for 2020-08-24 is going $67.05 (7.02%)

3 years ago
iHustle84 predicted that CVAC for 2020-08-24 is going $65.89 (-1.95%)

3 years ago
2poJeff predicted that CVAC for 2020-08-24 is going $66.01 (-1.77%)

Click to get the best stock tips daily for free!

About Curevac N.V.

Curevac N.V. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 cli... CVAC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT